Abstract Search

ey0018.8-3 | Important for Clinical Practice | ESPEYB18

8.3. Modified-release hydrocortisone in congenital adrenal hyperplasia

DP Merke , A Mallappa , W Arlt , A Brac de la Perriere , A Linden Hirschberg , A Juul , J Newell-Price , CG Perry , A Prete , DA Rees , N Reisch , N Stikkelbroeck , P Touraine , K Maltby , FP Treasure , J Porter , RJ Ross

J Clin Endocrinol Metab 2021; 106(5): e2063e2077.https://pubmed.ncbi.nlm.nih.gov/33527139/The authors report the findings of a 6-month, randomized, phase 3 trial, with a single arm extension, to investigate the efficacy, safety and tolerability of modified release hydrocortisone (MC-HC) replacement therapy versus standard glucocorticoid replacement therapy in 122 adult patients with c...

0 shares

ey0015.3-5 | Follow-up paper from Yearbook 2012 | ESPEYB15

3.5 Controlled Antenatal Thyroid Screening II: effect of treating maternal suboptimal thyroid function on child cognition

C Hales , PN Taylor , S Channon , R Paradice , K McEwan , L Zhang , M Gyedu , A Bakhsh , O Okosieme , I Muller , MS Draman , JW Gregory , C Dayan , JH Lazarus , DA Rees , M Ludgate

To read the full abstract: J Clin Endocrinol Metab 2018;103:1583-1591The Controlled Antenatal Thyroid Screening (CATS) study started in 2002 and was the first randomized controlled trial to evaluate the effect of screening and treatment of mild hypothyroidism during pregnancy on child cognition1. A large number of women (n=21,846) were recruited at a median ...

0 shares

ESPE Yearbook of Paediatric Endocrinology

8.3. Modified-release hydrocortisone in congenital adrenal hyperplasia

3.5 Controlled Antenatal Thyroid Screening II: effect of treating maternal suboptimal thyroid function on child cognition

BiosciAbstracts